Protecting Central Vision: Understanding the Risks, Early Detection, and Emerging Therapies for Age-Related Macular Degeneration
Age-Related Macular Degeneration (AMD) is the leading cause of irreversible vision loss in people over the age of 50 in developed countries, profoundly impacting the quality of life by damaging the macula, the part of the retina responsible for sharp, central vision. This insidious condition manifests in two primary forms—dry (atrophic) and wet (neovascular)—and gradually impairs the ability to perform crucial daily tasks such as reading, driving, and recognizing faces. Early detection, often through routine comprehensive eye exams including retinal imaging, is paramount because therapeutic strategies are most effective when implemented before significant, permanent central vision loss occurs.
